Ditchcarbon
  • Contact
  1. Organizations
  2. Traphaco Joint Stock Company
Public Profile
Pharmaceutical Preparation Manufacturing
VN
updated 2 months ago

Traphaco Joint Stock Company Sustainability Profile

Company website

Traphaco Joint Stock Company, commonly referred to as Traphaco, is a leading pharmaceutical enterprise headquartered in Vietnam. Established in 1972, the company has made significant strides in the healthcare sector, particularly in the production and distribution of herbal medicines and dietary supplements. With a strong operational presence across major regions in Vietnam, Traphaco is renowned for its commitment to quality and innovation. The company’s core offerings include a diverse range of herbal products, pharmaceuticals, and functional foods, distinguished by their adherence to traditional medicine principles combined with modern scientific research. Traphaco has achieved notable recognition in the market, positioning itself as a trusted brand in the Vietnamese pharmaceutical industry. Its dedication to sustainable practices and community health further solidifies its reputation as a pioneer in the sector.

DitchCarbon Score

How does Traphaco Joint Stock Company's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

22

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

Traphaco Joint Stock Company's score of 22 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.

22%

Let us know if this data was useful to you

Traphaco Joint Stock Company's reported carbon emissions

Traphaco Joint Stock Company, headquartered in Vietnam, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. Consequently, there are no recorded emissions in terms of Scope 1, 2, or 3. Additionally, the company has not established any documented reduction targets or commitments to climate initiatives, such as those outlined by the Science Based Targets initiative (SBTi). This lack of data suggests that Traphaco may still be in the early stages of developing a comprehensive climate strategy. As the company moves forward, it may consider setting measurable targets to align with industry standards and enhance its sustainability profile.

How Carbon Intensive is Traphaco Joint Stock Company's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Traphaco Joint Stock Company's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Traphaco Joint Stock Company's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Traphaco Joint Stock Company is in VN, which we do not have grid emissions data for.

Traphaco Joint Stock Company's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Traphaco Joint Stock Company has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Traphaco Joint Stock Company's Emissions with Industry Peers

Sanofi

FR
•
Pharmaceutical Preparation Manufacturing
Updated about 2 hours ago

Bristol-Myers Squibb

US
•
Pharmaceutical Preparation Manufacturing
Updated 1 minute ago

MEKOPHAR Chemical Pharmaceutical Joint Stock Company

VN
•
Pharmaceutical Preparation Manufacturing
Updated 11 days ago

Domesco Medical Import - Export Joint-Stock Corporation

VN
•
Pharmaceutical Preparation Manufacturing
Updated about 2 months ago

Otsuka Pharmaceutical Co., Ltd.

JP
•
Pharmaceutical Preparation Manufacturing
Updated about 2 months ago

Pfizer

US
•
Pharmaceutical Preparation Manufacturing
Updated about 1 hour ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251030.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy